These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30299160)

  • 1. Vinorelbine cationic liposomes modified with wheat germ agglutinin for inhibiting tumor metastasis in treatment of brain glioma.
    Xiao Y; Cheng L; Xie HJ; Ju RJ; Wang X; Fu M; Liu JJ; Li XT
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S524-S537. PubMed ID: 30299160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells.
    Li XT; Ju RJ; Li XY; Zeng F; Shi JF; Liu L; Zhang CX; Sun MG; Lou JN; Lu WL
    Oncotarget; 2014 Aug; 5(15):6497-511. PubMed ID: 25153726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer.
    Li XY; Shi LX; Yao XM; Jing M; Li QQ; Wang YL; Li QS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):100-112. PubMed ID: 33295825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
    Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
    Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
    Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
    Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma.
    Li XT; Tang W; Xie HJ; Liu S; Song XL; Xiao Y; Wang X; Cheng L; Chen GR
    J Liposome Res; 2019 Mar; 29(1):21-34. PubMed ID: 29166813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma.
    Liu Q; Zhou L; Lu R; Yang C; Wang S; Hai L; Wu Y
    Bioorg Med Chem; 2021 Jan; 29():115852. PubMed ID: 33189509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.
    Kong D; Hong W; Yu M; Li Y; Zheng Y; Ying X
    Int J Nanomedicine; 2022; 17():1087-1110. PubMed ID: 35313461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation.
    Li XT; He ML; Zhou ZY; Jiang Y; Cheng L
    Int J Pharm; 2015 Jun; 487(1-2):223-33. PubMed ID: 25895716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG
    Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT
    Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma.
    Xie HJ; Zhan-Dui N; Zhao J; Er-Bu AGA; Zhen P; ZhuoMa D; Sang T
    Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):596-605. PubMed ID: 34514904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.
    Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
    Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
    Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
    Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
    J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
    Wang Y; Ying X; Xu H; Yan H; Li X; Tang H
    Int J Nanomedicine; 2017; 12():1369-1384. PubMed ID: 28260885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer.
    Liu S; Song XL; Wang YH; Wang XM; Xiao Y; Wang X; Cheng L; Li XT
    J Drug Target; 2017 Jul; 25(6):541-553. PubMed ID: 28277825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.